Cardiovascular disease (CVD), including heart disease and stroke, is the main cause of death and a major cause of disability in Europe. It is estimated that 80% can be prevented. Small reductions in incidence and mortality lead to large health gains and reductions in direct and indirect health care costs. CVD costs the EU economy €196 billion every year and it is the main contributor to inequalities in health.

Health gains will particularly benefit less-advantaged groups. The EuroHeart II project will report on and analyse the current situation with regard to cardiovascular and circulatory diseases in the EU. The project will allow a strategic approach that will also help address other non-communicable diseases. The project will provide outputs that can be used to develop Community initiatives to promote cardiovascular health.

The EuroHeart II project receives co-funding from the European Union in the framework of  the Health programme.  The sole responsibility for the content of any publications made in the framework of this project lies with the author(s). The Executive Agency for Health and Consumers is not responsible for any use that may be made of the information contained herein.